Clinical Trial of Sir-Spheres® in Patients With Symptomatic or Progressive Hepatic Metastases From Neuroendocrine Tumors

NCT00466856 Phase 2 TERMINATED

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well internal radiation therapy works in treating patients with liver metastases from neuroendocrine tumors.

Details

Lead sponsor	Vanderbilt-Ingram Cancer Center
Phase	Phase 2
Status	TERMINATED
Enrolment	10
Start date	2003-12
Completion	2007-10

Conditions

• Head and Neck Cancer
• Islet Cell Tumor
• Metastatic Cancer
• Pheochromocytoma

Interventions

• octreotide acetate
• yttrium Y 90 resin microspheres

Primary outcomes

• Tumor response — at 1 year or until intervening death

Countries

United States